Health care

Sponsored Content: Retatrutide ‘wiped out’ fat in liver of obese patients

GettyImages 1018897944 910x652

By A.J. Hostetler More than 85% of obese participants with fatty liver disease in a clinical trial of the experimental drug retatrutide reduced their liver fat to the point where they would no longer be classified as having fatty liver disease, according to the Virginia Commonwealth University hepatologist leading the sub-study. Arun Sanyal, M.D., director… Read more »